SCHEMBL22226776

SCHEMBL22226776

CC1(C)C(=O)N[C@H](c2ccccc2)[C@H]1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CA2 P00918 2/20 0.37
MAPT P10636 2/20 0.37
KDM1A O60341 4/20 0.36
MAOA P21397 4/20 0.36
MAOB P27338 4/20 0.36
PDK2 Q15119 1/20 0.35
PDK4 Q16654 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
LMNA P02545 2/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPK1 P28482 1/20 0.34
HTR2B P41595 1/20 0.34
USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22204852 1.00 CHRNA7 (0.40) CHRNA7SMN1; SMN2MEN1KMT2ACA2
SCHEMBL22225733 1.00 CHRNA7 (0.40) CHRNA7SMN1; SMN2MEN1KMT2ACA2
SCHEMBL22204854 1.00 CHRNA7 (0.40) CHRNA7SMN1; SMN2MEN1KMT2ACA2
SCHEMBL22204962 0.77 SMN1; SMN2 (0.38) SMN1; SMN2MEN1KMT2ACA2MAPT
SCHEMBL22204958 0.77 SMN1; SMN2 (0.38) SMN1; SMN2MEN1KMT2ACA2MAPT
SCHEMBL22225734 0.77 SMN1; SMN2 (0.38) SMN1; SMN2MEN1KMT2ACA2MAPT
SCHEMBL22204960 0.77 SMN1; SMN2 (0.38) SMN1; SMN2MEN1KMT2ACA2MAPT
SCHEMBL22828891 0.76 ALDH1A1 (0.45) CHRNA7SMN1; SMN2MEN1KMT2ACA2
SCHEMBL22204850 0.76 ALDH1A1 (0.45) CHRNA7SMN1; SMN2MEN1KMT2ACA2
SCHEMBL22204848 0.76 ALDH1A1 (0.45) CHRNA7SMN1; SMN2MEN1KMT2ACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3986885-B1 SUBSTITUTED PYRROLIDINE AMIDES IV GRUENENTHAL GMBH (DE) 2023-05-03 EP disclosed
US-20220089573-A1 SUBSTITUTED PYRROLIDINE AMIDES III Grünenthal GmbH (DE) 2022-03-24 US disclosed
WO-2020254551-A1 SUBSTITUTED PYRROLIDINE AMIDES IV Grünenthal GmbH (DE) 2020-12-24 WO disclosed
US-20200223840-A1 SUBSTITUTED PYRROLIDINE AMIDES III GRUENENTHAL GMBH (DE) 2020-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200223840-A1 SUBSTITUTED PYRROLIDINE AMIDES III NR3C1, NR3C2, MC2R CHRNA7 1381/4885SMN1; SMN2 4659/4885MEN1 3553/4885
US-20220089573-A1 SUBSTITUTED PYRROLIDINE AMIDES III NR3C1, NR3C2, MC2R CHRNA7 1381/4885SMN1; SMN2 4659/4885MEN1 3553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.